Annual Total Expenses
$13.25 M
-$9.76 M-42.42%
01 December 2023
Summary:
Addex Therapeutics Ltd annual total expenses is currently $13.25 million, with the most recent change of -$9.76 million (-42.42%) on 01 December 2023. During the last 3 years, it has fallen by -$6.91 million (-34.28%). ADXN annual total expenses is now -72.35% below its all-time high of $47.90 million, reached on 31 December 2008.ADXN Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$781.80 K
-$340.10 K-30.31%
01 September 2024
Summary:
Addex Therapeutics Ltd quarterly total expenses is currently $781.80 thousand, with the most recent change of -$340.10 thousand (-30.31%) on 01 September 2024. Over the past year, it has dropped by -$9.29 million (-92.23%). ADXN quarterly total expenses is now -92.23% below its all-time high of $10.07 million, reached on 01 December 2023.ADXN Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADXN Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -92.2% |
| 3 y3 years | -34.3% | -84.6% |
| 5 y5 years | -24.2% | -82.4% |
ADXN Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -42.4% | at low | -92.2% | at low |
| 5 y | 5 years | -42.4% | at low | -92.2% | at low |
| alltime | all time | -72.3% | +573.8% | -92.2% | at low |
Addex Therapeutics Ltd Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $781.80 K(-30.3%) |
| June 2024 | - | $1.12 M(-4.0%) |
| Mar 2024 | - | $1.17 M(-88.4%) |
| Dec 2023 | $13.25 M(-42.4%) | $10.07 M(+725.5%) |
| Sept 2023 | - | $1.22 M(+6.7%) |
| June 2023 | - | $1.14 M(+21.8%) |
| Mar 2023 | - | $937.90 K(-77.9%) |
| Dec 2022 | $23.01 M(+14.1%) | $4.25 M(-10.3%) |
| Sept 2022 | - | $4.74 M(-37.1%) |
| June 2022 | - | $7.54 M(+16.1%) |
| Mar 2022 | - | $6.50 M(+28.1%) |
| Dec 2021 | $20.16 M(+19.2%) | $5.07 M(+9.3%) |
| Sept 2021 | - | $4.64 M(-23.2%) |
| June 2021 | - | $6.04 M(+36.8%) |
| Mar 2021 | - | $4.41 M(+7.7%) |
| Dec 2020 | $16.91 M | $4.10 M(+20.0%) |
| Sept 2020 | - | $3.41 M(-14.2%) |
| June 2020 | - | $3.98 M(-25.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $5.35 M(+20.5%) |
| Dec 2019 | $17.48 M(+129.0%) | $4.44 M(+2.6%) |
| Sept 2019 | - | $4.33 M(-11.1%) |
| June 2019 | - | $4.87 M(+26.9%) |
| Mar 2019 | - | $3.84 M |
| Dec 2018 | $7.64 M(+132.5%) | - |
| Dec 2017 | $3.28 M(+3.4%) | - |
| Dec 2016 | $3.18 M(+0.6%) | - |
| Dec 2015 | $3.16 M(+60.7%) | - |
| Dec 2014 | $1.97 M(-87.4%) | - |
| Dec 2013 | $15.60 M(-45.0%) | - |
| Dec 2012 | $28.37 M(-25.8%) | - |
| Dec 2011 | $38.25 M(+12.6%) | - |
| Dec 2010 | $33.98 M(-22.0%) | - |
| Dec 2009 | $43.55 M(-9.1%) | - |
| Dec 2008 | $47.90 M(+50.7%) | - |
| Dec 2007 | $31.78 M(+54.5%) | - |
| Dec 2006 | $20.57 M | - |
FAQ
- What is Addex Therapeutics Ltd annual total expenses?
- What is the all time high annual total expenses for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd quarterly total expenses?
- What is the all time high quarterly total expenses for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd quarterly total expenses year-on-year change?
What is Addex Therapeutics Ltd annual total expenses?
The current annual total expenses of ADXN is $13.25 M
What is the all time high annual total expenses for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high annual total expenses is $47.90 M
What is Addex Therapeutics Ltd quarterly total expenses?
The current quarterly total expenses of ADXN is $781.80 K
What is the all time high quarterly total expenses for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high quarterly total expenses is $10.07 M
What is Addex Therapeutics Ltd quarterly total expenses year-on-year change?
Over the past year, ADXN quarterly total expenses has changed by -$9.29 M (-92.23%)